Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
April 8, 2025
Patent Thickets and Product Hops: Challenges and Opportunities for Legislative Reform
William B Feldman
The New England Journal of Medicine
|
February 24, 2025
The Moral Injury of Inhaler Prescribing
William B Feldman, Gregg Furie
JAMA Health Forum
|
July 19, 2024
Use of Track One Prioritized Examination for Pharmaceutical Patents
S Sean Tu, William B Feldman
JAMA Network Open
|
June 14, 2023
The Rise and Fall of the Insulin Pricing Bubble
William B Feldman, Benjamin N Rome
BMJ (Clinical Research Ed.)
|
March 13, 2025
Active postmarketing device surveillance as a legislative priority
William B Feldman, Aaron S Kesselheim
The Lancet. Respiratory Medicine
|
October 25, 2019
When is the right time to discuss ECMO?
William B Feldman, Steven P Keller
Joint Commission Journal on Quality and Patient Safety
|
April 16, 2026
Healthcare Ethics Is a Key Underrecognized Step on the Road to High Reliability
Lindsay R Semler, William B Feldman
JAMA
|
September 15, 2023
The Problem of Limited-Supply Agreements for Medicare Price Negotiation
Sarah M E Gabriele, William B Feldman
JAMA
|
July 12, 2022
Over-the-Counter Availability of Rescue Inhalers for Asthma-Reply
William B Feldman, Jerry Avorn, Aaron S Kesselheim
Stroke
|
May 6, 2017
Response by Feldman et al to Letter Regarding Article, "Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014"
William B Feldman, Anthony S Kim, Winston Chiong
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
April 8, 2025
Patent Thickets and Product Hops: Challenges and Opportunities for Legislative Reform
William B Feldman
The New England Journal of Medicine
|
February 24, 2025
The Moral Injury of Inhaler Prescribing
William B Feldman, Gregg Furie
JAMA Health Forum
|
July 19, 2024
Use of Track One Prioritized Examination for Pharmaceutical Patents
S Sean Tu, William B Feldman
JAMA Network Open
|
June 14, 2023
The Rise and Fall of the Insulin Pricing Bubble
William B Feldman, Benjamin N Rome
BMJ (Clinical Research Ed.)
|
March 13, 2025
Active postmarketing device surveillance as a legislative priority
William B Feldman, Aaron S Kesselheim
The Lancet. Respiratory Medicine
|
October 25, 2019
When is the right time to discuss ECMO?
William B Feldman, Steven P Keller
Joint Commission Journal on Quality and Patient Safety
|
April 16, 2026
Healthcare Ethics Is a Key Underrecognized Step on the Road to High Reliability
Lindsay R Semler, William B Feldman
JAMA
|
September 15, 2023
The Problem of Limited-Supply Agreements for Medicare Price Negotiation
Sarah M E Gabriele, William B Feldman
JAMA
|
July 12, 2022
Over-the-Counter Availability of Rescue Inhalers for Asthma-Reply
William B Feldman, Jerry Avorn, Aaron S Kesselheim
Stroke
|
May 6, 2017
Response by Feldman et al to Letter Regarding Article, "Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014"
William B Feldman, Anthony S Kim, Winston Chiong
Page
of 11